insitro

Origin

insitro is based in South San Francisco, California, United States.

Company History

Founded in 2018 by Daphne Koller, a renowned AI researcher and co-founder of Coursera, insitro emerged as a pioneering drug discovery company. The company was established with the vision of transforming pharmaceutical research through machine learning and computational biology. Since its inception, insitro has raised significant funding, including a $143 million Series A round in 2019 and a $400 million Series B round in 2021, making it one of the most well-funded AI-driven drug discovery companies.

Mission

To use machine learning to transform the way medicines are discovered and developed, making the process faster, more efficient, and more successful.

Vision

To revolutionize drug discovery by creating a new paradigm that combines cutting-edge AI technology with innovative experimental approaches to accelerate the development of life-saving treatments.

Values

• Scientific Rigor: Commitment to high-quality science and data-driven decision making
• Innovation: Pushing the boundaries of what's possible in drug discovery
• Collaboration: Working together internally and with partners to achieve breakthrough results
• Patient Focus: Keeping patients at the center of everything they do
• Transparency: Maintaining open communication and honest assessment of progress

Products and Services

insitro develops AI-powered drug discovery platforms that integrate machine learning with experimental biology. Their primary focus is on creating predictive models for drug efficacy and safety, particularly in areas like metabolic diseases, neurodegeneration, and oncology.

Latest Technologies and Trends

The company leverages deep learning, computer vision, and multi-modal AI approaches to analyze cellular imagery, genomics data, and chemical properties. They employ automated high-throughput experimentation combined with sophisticated machine learning models to predict drug behavior and identify promising therapeutic candidates.

Curiosities

• Founded by Daphne Koller, who previously co-founded Coursera and was a Stanford AI professor
• One of the most well-funded AI drug discovery companies globally
• Focuses on creating their own experimental data rather than relying solely on public datasets
• Has partnerships with major pharmaceutical companies including Roche and Bristol Myers Squibb